期刊文献+

不同小鼠腹水型肝癌细胞增殖侵袭能力与膜联蛋白A7的亚细胞定位和亚型表达研究 被引量:2

Study of proliferation and invasion activity in different mouse hepatocarcinoma cell lines and location and isoform expression of Annexin A7
在线阅读 下载PDF
导出
摘要 目的探讨在小鼠淋巴道转移潜能不同的肝癌细胞中,肝癌细胞增殖侵袭能力与膜联蛋白A7的亚细胞定位和亚型的表达。方法以小鼠腹水型肝癌高、低淋巴道转移潜能不同的细胞株Hca-F细胞和Hca-P细胞为研究对象,通过CCK8法检测细胞的增殖能力,Transwell小室检测细胞侵袭能力;Western blotting方法检测膜联蛋白A7在体外增殖侵袭能力不同的肿瘤细胞中的亚细胞定位和亚型的变化。结果发现Hca-F细胞无论是增殖能力还是侵袭能力都高于Hca-P细胞。膜联蛋白A7在Hca-F细胞和Hca-P细胞主要为47 kD亚型表达,而51 kD亚型只少量表达于细胞浆。47 kD亚型在Hca-F细胞的细胞浆、细胞膜、细胞器膜以及细胞骨架中的表达均明显高于Hca-P细胞,分别为(73%±7%)v(s49%±19%)、(36%±8%)v(s24%±9%)和(53%±7%)v(s40%±12%)(均P<0.05)。结论膜联蛋白A7的47 kDa亚型在细胞浆、细胞膜、细胞器膜和细胞骨架的定位表达,可能与肝癌细胞增殖侵袭能力密切相关。 [Objective] To study the cell proliferation and invasion activity in mouse hepatocarcinoma cell lines with different lymphatic metastatic potential and the location and isoform expression of Annexin A7. [Methods] Mouse hepatoearcinoma cell lines Hea-F with high lymphatic metatastie potential and Hea-P with low lymphatic metastatic potential were used. Cell proliferation was assessed by cell counting kit-8 (CCK8) assay. Cell invasion ability was analyzed by the Boyden-transwell assay. The location and isoform expression of annexin A7 were evaluated by subcellular fractionation kit and western blotting analysis. [Results] The perliferation and invasion ability were higher in Hca-F cell than those in Hca-P cell. 47 kD isoform was pre- sent in cytoplasm, membrane and cytoskeleton. And they were higher in Hca-F than those in Hca-P, where 51 kD was in the cytoplasm exclusively. [Conclusion] The location of annexin A7 47 kD isoform might at- tribute to tumor lymphatic metastasis.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2012年第35期9-13,共5页 China Journal of Modern Medicine
基金 国家自然科学基金(No:81071725) 教育部留学回国人员科研启动基金
关键词 膜联蛋白A7 亚细胞定位 蛋白亚型 增殖与侵袭 Annexin A7 subcellular fractionation isoform pediferation and invasion
  • 相关文献

参考文献15

  • 1QAZ1 AS, SUN M, HUANG Y, et al. Subcellular proleomics:determination of specific location and expression levels of lym- phatic metastasis associated proteins in hepatocellular carcinoma by subcellular fractionation[J]. Biomed Pharmacother, 2011, 65(6): 407-416.
  • 2SUN MZ, LIU S, TANG J, et al. Proteomics analysis of two mice hepatocarcinoma ascites syngeneic cell lines with high and low lymph node metastasis rates provide potential protein markers for tumor malignancy attributes to lymphatic metastasis[J]. Pro- teomics, 2009, 9(12): 3285-3302.
  • 3ZHANG J, SONG M, WANG J, et al. Euoyl coenzyme A hy- dratase 1 is an important factor in the lymphatic metastasis of tumors[J]. Biomed Pharmacother, 2011, 65(3): 157-162.
  • 4宋丽萍,华子春,张欣,轩楠,邢海燕.重组改良型人膜联蛋白的核素标记及体内显像的实验研究[J].中国现代医学杂志,2010,20(17):2579-2581. 被引量:2
  • 5TOROSYAN Y, DOBI A, GLASMAN M, et al. Role of mul- ti-hnRNP nuclear complex in regulation of tumor suppressor ANXA7 in prostate cancer cells[J]. Oncogene, 2010, 29(17): 2457 -2466.
  • 6TOROSYAN y, SIMAKOVA O, NAGA S, et al. Annexin-A7 protects normal prostate ceils and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells[J]. Int J Cancer, 2009, 125: 2528-2539.
  • 7SRIVASTAVA M, TOROSYAN Y, RAFFELD M, et al. ANXA7 expression represents hormone-relevant tumor suppression in dif- ferent cancers[J]. Int J Cancer, 2007, 121: 2628-2636.
  • 8TANIUCHI K, YOKOTANI K, SAIBARA T. BART inhibits pancreatic cancer cell invasion by PKC α inactivation through bind- ing to ANXT[J]. PLoS One, 2012, 7(4): 35674.
  • 9BREDEL M, SCHOLTENS DM, HARSH GR, et al. A network model of a cooperative genetic landscape in brain tumors[J]. JA- MA, 2009, 302(3): 261-275.
  • 10JI H, MORITZ RL, KIM YS, et al. Analysis of ras-induced oncogenic transformation of NIH-3T3 ceils using differential dis- play 2-DE proteomics[J]. Electrophoresis, 2007, 28: 1997-2008.

二级参考文献24

共引文献8

同被引文献20

  • 1Gerke V, Creutz CE, Moss SE. Annexins: linking Ca2+ signaling to membrane dynamics[J]. Nat Rev Mol Cell Bio, 2005, 6(6) : 449 -461.
  • 2Rescher U, Gerke V. Annexins-unique membrane binding proteins with diverse functions[J]. J Cell Sci, 2004, 117 (13):2631- 2639.
  • 3Fatimathas L, Moss SE. Annexins as disease modifiers[ J]. Histol Histopathol, 2010, 25 ( 4 ) : 527-532.
  • 4Srivastava M, Bubendorf L, Srikantan V, et al. ANX7, a candidate tumor suppressor gene for prostate cancer[ J]. Proc Natl Acad Sci USA, 2001, 98(8) :4575-4580.
  • 5Srivastava M, Bubendorf L, Raffeld M, et al. Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patlents[J]. Clin Cancer Res, 2004, 10(7) :2344-2350.
  • 6Kataoka TR, Ito A, Asada H, et al. Annexin VII as a novel marker for invasive phenotype of malignant melanoma [ J ]. Jpn J Cancer Res, 2000, 91(1):75-83.
  • 7Yadav AK, Renfrow JJ, Schohens DM, et al. Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas [ J ]. JAMA, 2009, 302 ( 3 ) : 276- 289.
  • 8Creutz CE, Pazoles C J, Pollard HB. Identification and purification of an adrenal medullary protein (synexin) that causes calcium-dependent aggregation of isolated chromaffin granules [ J ]. J Biol Chem, 1978, 253(8) :2858-2866.
  • 9Srivastava M, Torosyan Y, Raffeld M, et al. ANXA7 expression represents bormonerelevant tumor suppression indifferent cancers [J]. Int J Cancer, 2007, 121(12) : 2628-2636.
  • 10Ji H, Moritz RL, Kim YS, et al. Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential display 2-DE proteomics [ J ]. Electrophoresis, 2007, 28 ( 12 ) : 1997- 2008.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部